4.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Precedente Chiudi:
$4.29
Aprire:
$4.29
Volume 24 ore:
2.30M
Relative Volume:
0.82
Capitalizzazione di mercato:
$421.93M
Reddito:
$775.09M
Utile/perdita netta:
$-58.68M
Rapporto P/E:
-32.28
EPS:
-0.1326
Flusso di cassa netto:
$64.06M
1 W Prestazione:
-1.83%
1M Prestazione:
-4.89%
6M Prestazione:
-8.35%
1 anno Prestazione:
-46.43%
Goodrx Holdings Inc Stock (GDRX) Company Profile
Nome
Goodrx Holdings Inc
Settore
Industria
Telefono
(855) 268-2822
Indirizzo
2701 OLYMPIC BOULEVARD, SANTA MONICA
Confronta GDRX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
GDRX
Goodrx Holdings Inc
|
4.28 | 1.49B | 775.09M | -58.68M | 64.06M | -0.1326 |
![]()
VEEV
Veeva Systems Inc
|
270.06 | 44.25B | 2.97B | 809.93M | 1.33B | 4.87 |
![]()
TEM
Tempus Ai Inc
|
78.12 | 13.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
68.52 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
97.70 | 7.68B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
37.23 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-08-11 | Downgrade | Raymond James | Strong Buy → Outperform |
2024-12-04 | Iniziato | Mizuho | Neutral |
2024-08-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
2024-05-23 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2024-05-16 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2024-03-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
2024-02-26 | Iniziato | Leerink Partners | Outperform |
2024-01-02 | Downgrade | BofA Securities | Buy → Underperform |
2023-08-10 | Aggiornamento | DA Davidson | Neutral → Buy |
2023-07-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
2022-12-01 | Iniziato | Citigroup | Buy |
2022-11-04 | Aggiornamento | JP Morgan | Underweight → Neutral |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2022-09-07 | Iniziato | Truist | Hold |
2022-08-12 | Iniziato | DA Davidson | Neutral |
2022-06-10 | Downgrade | Goldman | Buy → Neutral |
2022-06-06 | Ripresa | BofA Securities | Buy |
2022-06-01 | Downgrade | Robert W. Baird | Outperform → Neutral |
2022-05-10 | Downgrade | Evercore ISI | Outperform → In-line |
2022-05-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2022-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
2022-05-10 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2022-04-11 | Iniziato | Wells Fargo | Equal Weight |
2022-04-07 | Iniziato | Guggenheim | Buy |
2022-04-01 | Ripresa | Credit Suisse | Neutral |
2022-03-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2022-03-01 | Reiterato | Barclays | Overweight |
2022-03-01 | Reiterato | BofA Securities | Neutral |
2022-03-01 | Downgrade | Cowen | Outperform → Market Perform |
2022-03-01 | Downgrade | Credit Suisse | Outperform → Neutral |
2022-03-01 | Reiterato | Evercore ISI | Outperform |
2022-03-01 | Reiterato | Goldman | Buy |
2022-03-01 | Reiterato | JP Morgan | Underweight |
2022-03-01 | Reiterato | RBC Capital Mkts | Outperform |
2022-03-01 | Reiterato | SVB Leerink | Outperform |
2022-01-07 | Iniziato | Goldman | Buy |
2021-12-21 | Iniziato | Stephens | Overweight |
2021-12-02 | Iniziato | Jefferies | Buy |
2021-08-31 | Aggiornamento | Barclays | Equal Weight → Overweight |
2021-08-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2021-05-28 | Iniziato | Robert W. Baird | Neutral |
2021-04-06 | Ripresa | Evercore ISI | Outperform |
2021-01-25 | Iniziato | Guggenheim | Buy |
2020-11-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2020-11-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-10-19 | Iniziato | Barclays | Equal Weight |
2020-10-19 | Iniziato | BofA Securities | Neutral |
2020-10-19 | Iniziato | Citigroup | Buy |
2020-10-19 | Iniziato | Cowen | Outperform |
2020-10-19 | Iniziato | Credit Suisse | Outperform |
2020-10-19 | Iniziato | Deutsche Bank | Hold |
2020-10-19 | Iniziato | Goldman | Neutral |
2020-10-19 | Iniziato | JP Morgan | Neutral |
2020-10-19 | Iniziato | Morgan Stanley | Overweight |
2020-10-19 | Iniziato | RBC Capital Mkts | Sector Perform |
2020-10-19 | Iniziato | SVB Leerink | Outperform |
2020-10-19 | Iniziato | UBS | Buy |
Mostra tutto
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
Are Investors Undervaluing GoodRx Holdings, Inc. (NASDAQ:GDRX) By 50%? - uk.finance.yahoo.com
GoodRx (GDRX) Unveils Lifecycle to Enhance Engineering Methodologies - MSN
Will GoodRx Holdings Inc. continue its uptrendTrade Risk Summary & Low Drawdown Trading Strategies - Newser
GoodRx Holdings Inc. stock daily chart insightsWeekly Loss Report & Fast Moving Trade Plans - Newser
When is the best time to exit GoodRx Holdings Inc.CEO Change & Daily Entry Point Alerts - Newser
Can swing trading help recover from GoodRx Holdings Inc. losses2025 Risk Factors & Weekly Hot Stock Watchlists - Newser
GoodRx Holdings, Inc. shares rise 2.56% premarket after launching 'The Savings Wrangler' brand campaign. - AInvest
Is GoodRx Holdings Inc. a candidate for recovery playMarket Activity Report & Smart Swing Trading Techniques - Newser
What MACD signals say about GoodRx Holdings Inc.2025 Macro Impact & Capital Protection Trading Alerts - Newser
Comparing GoodRx Holdings Inc. in custom built stock radars2025 Price Momentum & High Return Stock Watch Alerts - Newser
Chart based analysis of GoodRx Holdings Inc. trends2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Can technical indicators confirm GoodRx Holdings Inc.’s reversalJuly 2025 Technicals & Verified Momentum Stock Alerts - Newser
Best data tools to analyze GoodRx Holdings Inc. stock2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
Is GoodRx Holdings Inc. stock reversal real or fakeJuly 2025 PostEarnings & AI Based Buy/Sell Signal Reports - Newser
Is GoodRx Holdings Inc. forming a reversal pattern2025 Fundamental Recap & Precise Trade Entry Recommendations - Newser
Healthcare Giant GoodRx Unveils 'Savings Wrangler' Campaign After Helping Americans Save $85B on Prescriptions - Stock Titan
Earnings visualization tools for GoodRx Holdings Inc.Chart Signals & Verified Short-Term Plans - Newser
Can momentum traders help lift GoodRx Holdings Inc.Weekly Stock Report & Daily Profit Maximizing Tips - Newser
What are GoodRx Holdings Inc.’s recent SEC filings showingTake Profit & Safe Capital Growth Stock Tips - khodrobank.com
How to build a dashboard for GoodRx Holdings Inc. stockGold Moves & Breakout Confirmation Trade Signals - Newser
Will GoodRx Holdings Inc. outperform during market rallies2025 Biggest Moves & Risk Controlled Stock Pick Alerts - خودرو بانک
GoodRx’s SWOT analysis: prescription savings firm faces pharmacy headwinds - Investing.com
How to read the order book for GoodRx Holdings Inc.Trade Risk Report & Low Drawdown Trading Techniques - Newser
Leerink Partners Reiterates a Buy Rating on GoodRx Holdings (GDRX) With a $6 PT - MSN
How to build a custom watchlist for GoodRx Holdings Inc.Gap Down & Free High Accuracy Swing Entry Alerts - Newser
Is GoodRx Holdings Inc. stock poised for growthGap Up & Safe Capital Allocation Plans - Newser
Published on: 2025-08-31 19:43:55 - Newser
Live market analysis of GoodRx Holdings Inc.Portfolio Gains Summary & Free Expert Verified Stock Movement Alerts - Newser
Technical signs of recovery in GoodRx Holdings Inc.Insider Buying & Long Hold Capital Preservation Plans - Newser
Published on: 2025-08-31 14:02:00 - Newser
Historical volatility pattern of GoodRx Holdings Inc. visualizedEarnings Growth Report & Reliable Volume Spike Trade Alerts - Newser
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital - 富途牛牛
GoodRx Holdings GDRX Given Buy Rating by Leerink Partners with $6 Price Target - AInvest
GoodRx Holdings Inc. stock chart pattern explainedTrade Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Technical Models Suggest GoodRx Holdings Inc. May Rebound Soon getLinesFromResByArray error: size == 0 - thegnnews.com
Goodrx Holdings Inc Azioni (GDRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Goodrx Holdings Inc Azioni (GDRX) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Spectrum Equity VII, L.P. | 10% Owner |
Jul 03 '25 |
Sale |
4.80 |
10,677 |
51,226 |
0 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):